References
- Jones J, Mosher W, Daniels K. Current contraceptive use in the United States, 2006–2010, and changes in patterns of use since 1995. Natl Health Stat Report. 2012;60:1–25.
- Kraemer DF, Yen PY, Nichols M. An economic comparison of female sterilization of hysteroscopic tubal occlusion with laparoscopic bilateral tubal ligation. Contraception. 2009;80:254–260.
- Podolsky ML, Desai NA, Waters TP, Nyirjesy P. Hysteroscopic tubal occlusion: sterilization after failed laparoscopic or abdominal approaches. Obstet Gynecol. 2008;111:513–515.
- Yang R, Ma C, Qiao J et al. The usefulness of transvaginal hydrolaparoscopy in infertile women with abnormal hysterosalpingogram results but with no obvious pelvic pathology. Eur J Obstet Gynecol Reprod Biol. 2011;155:41–43.
- Chapa HO, Venegas G. Preprocedure patient preferences and attitudes toward permanent contraceptive options. Patient Prefer Adherence. 2012;6:331–336.
- Yu E. Materials in the Essure system (ESS305). Technical specifications provided by Conceptus Office of Regulatory Affairs: Product information. 20 August 2007.
- Brief Summary of the Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee Meeting—September 24, 2015. Department of Health & Human Services, U.S. Public Health Service, FDA (Washington, DC): 1-2. Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/ObstetricsandGynecologyDevices/UCM464487.pdf.
- Rabin RC. Long-term data on complications adds to criticism of contraceptive implant. New York Times May 4, 2015: A11.
- Ricci G, Restaino S, Di Lorenzo G et al. Risk of Essure microinsert abdominal migration: Case report and review of literature. Ther Clin Risk Manag. 2014;10:963–968.
- MAUDE (Manufacturer & User Facility Device Experience) Adverse Event Report: Bayer Healthcare LLC Essure Device, Occlusion, Tubal, Contraceptive. U.S. FDA Medical Device Database 2015. [cited 2015 Sep 15]. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=4531887.
- Dhruva SS, Ross JS, Gariepy AM. Revisiting Essure –Toward safe and effective sterilization. N Engl J Med. 2015;373(15):e17.
- Gordon D, Sherk SD. Hysterectomy. Encyclopedia of Surgery. [cited 2015 Sep 20]. Available from: http://www.surgeryencyclopedia.com/.
- Lannon BM, Lee SY. Techniques for removal of the Essure hysteroscopic tubal occlusion device. Fertil Steril. 2007;88:497.e13–e14.
- Albright CM, Frishman GN, Bhagavath B. Surgical aspects of removal of Essure microinsert. Contraception. 2013;88:334–336.
- Brito LG, Cohen SL, Goggins ER et al. Essure surgical removal and subsequent symptom resolution: Case series and follow-up survey. J Minim Invasive Gynecol. 2015;22:910–913.
- Mao J, Pfeifer S, Schlegel P, Sedrakyan A. Safety and efficacy of hysteroscopic sterilization compared with laparoscopic sterilization: An observational cohort study. BMJ. 2015;351:h5162.